Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates
Australia’s Economic Growth Slows in Q3 Despite Strong Investment Activity
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation 



